Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass.

Autor: Webber JW; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Wollborn L; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA., Mishra S; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA., Vitonis AF; Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham Women's Hospital, Boston, MA, USA., Cramer DW; Harvard Medical School, Boston, MA, USA; Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham Women's Hospital, Boston, MA, USA., Phan RT; Aspira Women's Health, Trumbull, CT, USA., Pappas TC; Aspira Women's Health, Trumbull, CT, USA., Stawiski K; Department of Biostatistics and Translational Medicine, Medical University of Łódź, Łódź, Poland., Fendler W; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biostatistics and Translational Medicine, Medical University of Łódź, Łódź, Poland., Chowdhury D; Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Elias KM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: kelias@bwh.harvard.edu.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Nov; Vol. 190, pp. 124-130. Date of Electronic Publication: 2024 Aug 23.

Ovarian Cancer surgical consideration is markedly improved by the neural network powered-MIA3G multivariate index assay.

Autor: Roy Choudhury M; Department of Research and Development, Aspira Women's Health, Austin, TX, United States., Pappas TC; Department of Research and Development, Aspira Women's Health, Austin, TX, United States., Twiggs LB; Division of Clinical Operations and Medical Affairs, Aspira Women's Health, Austin, TX, United States., Caoili E; Department of Regulatory Affairs and Quality Assurance, Aspira Women's Health, Shelton, CT, United States., Fritsche H; Aspira Labs, Aspira Women's Health, Austin, TX, United States., Phan RT; Department of Research and Development, Aspira Women's Health, Austin, TX, United States.; Division of Clinical Operations and Medical Affairs, Aspira Women's Health, Austin, TX, United States.; Aspira Labs, Aspira Women's Health, Austin, TX, United States.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2024 May 02; Vol. 11, pp. 1374836. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).

Validation of a gene expression signature to measure immune quiescence in kidney transplant recipients in the CLIA setting.

Autor: Cheung R; CareDx, Inc., Brisbane, CA 94005, USA., Xu H; CareDx, Inc., Brisbane, CA 94005, USA., Jin X; CareDx, Inc., Brisbane, CA 94005, USA., Tian W; CareDx, Inc., Brisbane, CA 94005, USA., Pinney K; CareDx, Inc., Brisbane, CA 94005, USA., Bu L; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN 55905, USA., Stone S; CareDx, Inc., Brisbane, CA 94005, USA., Woodward RN; CareDx, Inc., Brisbane, CA 94005, USA., Agrawal N; CareDx, Inc., Brisbane, CA 94005, USA., Dholakia S; CareDx, Inc., Brisbane, CA 94005, USA., Phan RT; CareDx, Inc., Brisbane, CA 94005, USA.

Publikováno v: Biomarkers in medicine [Biomark Med] 2022 Jun; Vol. 16 (8), pp. 647-661. Date of Electronic Publication: 2022 Apr 29.

Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.

Autor: Liao W; Division of Hematology-Oncology, UCLA-VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA. ericliaowei@gmail.com., Jordaan G; Division of Hematology-Oncology, UCLA-VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA. gwenrobyn@yahoo.com., Nham P; Department of Pathology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA. Phillipp.Nham@va.gov., Phan RT; Department of Pathology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA. Ryan.Phan@va.gov., Pelegrini M; Department of Molecular, Cell and Developmental Biology, UCLA, Los Angeles, CA, USA. matteop@mcdb.ucla.edu., Sharma S; Division of Hematology-Oncology, UCLA-VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA. sasharma@mednet.ucla.edu.; UCLA West Los Angeles VA Medical Center, 11301 Wilshire Blvd, Bldg 304, Rm E1-115, Los Angeles, CA, 90073, USA. sasharma@mednet.ucla.edu.

Publikováno v: BMC cancer [BMC Cancer] 2015 Oct 16; Vol. 15, pp. 714. Date of Electronic Publication: 2015 Oct 16.